Balance Sheet Data

Ascendis Pharma A/S (ASND)

$88.79

+0.07 (+0.08%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 195.35277.86598.11718.80682.061,488.113,652.668,965.6822,006.8354,017.14
Total Cash (%)
Account Receivables 2.382.635.417.3423.1923.8458.52143.63352.55865.35
Account Receivables (%)
Inventories ----75.41185.09454.311,115.122,737.146,718.47
Inventories (%)
Accounts Payable 23.7719.7427.7721.9059.42115.56283.65696.231,708.954,194.71
Accounts Payable (%)
Capital Expenditure -0.94-2.65-5.16-21.55-24.23-28.51-69.98-171.76-421.60-1,034.85
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.